349
Views
4
CrossRef citations to date
0
Altmetric
Reviews

Recent patenting activities in the discovery and development of vasopressin V2 receptor agonists

, PhD
Pages 579-586 | Published online: 25 May 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Magdalena J Ślusarz. (2015) Vasopressin V1a and V1b receptor modulators: a patent review (2012 – 2014). Expert Opinion on Therapeutic Patents 25:6, pages 711-722.
Read now

Articles from other publishers (3)

Ebru Arioglu-Inan & Gizem Kayki-Mutlu. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology 634 655 .
Marianna Ranieri, Annarita Di Mise, Grazia Tamma & Giovanna Valenti. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology 656 669 .
Jeffrey P. Weiss, Jerry G. Blaivas, Marco H. Blanker, Donald L. Bliwise, Roger R. Dmochowski, Marcus Drake, Catherine E. DuBeau, Adonis Hijaz, Raymond C. Rosen, Philip E.V. Van Kerrebroeck & Alan J. Wein. (2013) The New England Research Institutes, Inc. (NERI) Nocturia Advisory Conference 2012: focus on outcomes of therapy. BJU International 111:5, pages 700-716.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.